Coronary heart disease, type 2 diabetes mellitus and cardiovascular disease risk factors: A study on a middle-aged and elderly population

Archives of Gerontology and Geriatrics

Volumn 29, Issue 2, 1999, Pages 175-181

  Giansanti, Roberto ^a   Rabini, Rosa Anna ^a   Romagnoli, Fabio ^a   Fumelli, Daniele ^a   Sorichetti, Pierluigi ^a   Boemi, Massimo ^a   Fumelli, Paolo ^a  

^a INRCA   (Italy)

Author keywords

Coronary heart disease; Hypercholesterolemia; Hyperlipidemia; Hypertension; Type 2 diabetes mellitus

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; DISEASE DURATION; FEMALE; GERIATRIC DISORDER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0032886818     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(99)00031-X     Document Type: Article

References (16)

1. Barrett-Connor E., Wingard D.L. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am. J. Epidemiol. 118:1983;489-496.
2. Bierman E.L. Atherogenesis in diabetes. Arterioscler. Thromb. 12:1992;647-656.
3. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycemia and therapeutic prospects. Diabetologia. 36:1993;1119-1125.
4. Ellis G. An automated 'high-pressure' liquid-chromatographic assay for hemoglobin A1c. Clin. Chem. 30:1984;1746-1752.
5. Harris M.I., Entmacher P.S. Mortality from diabetes. Harris M.I., Hamman R.F. Diabetes in America. 1985;US Government Printing Office. NIH Publication No. 85-1468.
6. Kannell W.B., Hjortland M., Castelli W.P. Role of diabetes in cardiac disease: conclusions from population studies. The Framingham Study. Am. J. Cardiol. 34:1978;29-34.
7. Laakso M. Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies. Ann. Intern. Med. 124:1996;127-130.
8. Lyons T.J. Lipoprotein glycation and its metabolic consequences. Diabetes. 41(Suppl. 2):1992;67-73.
9. Morrish N.J., Stevens L.K., Head J. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics). 11. Associated risk factors. Diabetologia. 33:1990;542-548.
10. Pyörälä K., Laakso M., Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab. Rev. 3:1987;463-524.
11. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
12. Stamler J., Wentworth D., Neaton J.D. Diabetes and risk of coronary, cardiovascular, and all causes mortality: findings for 356,000 men screened by the Multiple Risk Factor Intervention Trial (MRFIT). Circulation. 70(Suppl. 2):1984;161-190.
13. Stamler, J., Vaccaro, O., Neaton, J.D., Wentworth, D., for the Multiple Risk Factor Intervention Trial Research Group, 1993. Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16, 434-444.
14. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J. Med. 329:1993;977-986.
15. West K.M., Ahuja M.M., Bennett P.H., Czyzyk A., De Acosta O.M., Fuller J.H. The role of circulating glucose and triglyceride concentrations and their interaction with other risk factors as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care. 6:1983;361-369.
16. Diabetes Mellitus: Report of a WHO Study Group. 1985;World Health Organization, Geneva. Technical Report Series No. 727.